Nu Skin(US:NUS)2026-02-12 23:02Financial Data and Key Metrics Changes - For 2025, the company reported adjusted earnings per share of $1.27, up from $0.84 in the previous year, representing a 51% growth [17] - Fourth quarter revenue was $370 million, with earnings per share of $0.29, aligning with expectations [18] - Gross margin for the fourth quarter was 70.7%, down from 71.4% in the prior year, while the core Nu Skin business gross margin improved to 77.6%, up 100 basis points from the prior year [18][19] Business Line Data and Key Metrics Changes - The core Nu Skin business achieved a gross margin of 77.4% for the full year, an 80 basis point improvement over the prior year [20] - Selling expense for the core business was 40.3% for the year, with expectations to maintain this level as the company drives adoption of its enhanced compensation plan [21] Market Data and Key Metrics Changes - The company initiated pre-market operations in India in November 2025, with a formal market opening anticipated in late 2026, targeting a significant long-term growth opportunity [5][12] - Latin America continues to show strong performance, contributing positively to the company's growth strategy [24][45] Company Strategy and Development Direction - The company aims to become the world's leading intelligent beauty, wellness, and lifestyle leadership opportunity platform, focusing on three strategic priorities: launching the Prysm iO Intelligent Wellness Platform, expanding into emerging markets like India, and improving operational performance [6][12][16] - The Prysm iO platform is expected to enhance customer engagement and lifetime value through intelligent insights and personalized recommendations [10][11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in returning to growth by the end of 2026, despite inherent switching costs associated with transitioning the business [5][16] - The company anticipates a revenue range of $1.35 billion to $1.5 billion for 2026, with earnings per share projected between $0.80 and $1.20 [25][26] Other Important Information - The company ended the quarter with approximately $240 million in cash and reduced outstanding debt to $224 million, resulting in an expanded net cash position [23] - The company returned approximately $11.8 million in dividends and $20 million in share repurchases during the year [23] Q&A Session Summary Question: Insights on Prysm's revenue contribution - Management indicated that the placement of Prysm devices will lead to subscription revenue over time, with an estimate of placing 100,000 devices by the end of 2026, potentially generating around $30 million in device sales [33] Question: Thoughts on the India market potential - Management sees significant long-term potential in India, focusing on establishing local manufacturing and logistics, with a conservative revenue forecast for the initial year [36][37] Question: Guidance considerations and key leverage points - Management discussed the importance of gross margin expansion and maintaining selling expenses around 40% while managing general and administrative costs in line with revenue [39][41] Question: Other portfolio performance insights - Management highlighted the successful rollout of the Tru Face skincare line and ongoing improvements in various markets, including China and Latin America [43][45]